{
  "disease_name": "Aspartylglucosaminuria",
  "orpha_code": "93",
  "drugs": [
    {
      "name": "Adeno-associated viral vector serotype 9 encoding a codon-optimised human aspartylglucosaminidase transgene",
      "substance_url": "/en/drug/substance/604867?name=93&mode=orpha&region=&status=all",
      "substance_id": "604867",
      "regulatory_url": "/en/drug/regulatory/604868?name=93&mode=orpha&region=",
      "regulatory_id": "604868",
      "orpha_substance_code": "ORPHA:93",
      "details": [
        "Adeno-associated viral vector serotype 9 encoding a codon-optimised human aspartylglucosaminidase transgene(Medicinal product                        - 19/10/2020)Disease(s) concernedORPHA:93 Aspartylglucosaminuria",
        "Adeno-associated viral vector serotype 9 encoding a codon-optimised human aspartylglucosaminidase transgene(Medicinal product                        - 19/10/2020)",
        "(Medicinal product                        - 19/10/2020)",
        "Disease(s) concernedORPHA:93 Aspartylglucosaminuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/604867?name=93&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 9 encoding a codon-optimised human aspartylglucosaminidase transgene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/93",
          "text": "ORPHA:93 Aspartylglucosaminuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/604868?name=93&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant human aspartylglucosaminidase",
      "substance_url": "/en/drug/substance/418152?name=93&mode=orpha&region=&status=all",
      "substance_id": "418152",
      "regulatory_url": "/en/drug/regulatory/437286?name=93&mode=orpha&region=",
      "regulatory_id": "437286",
      "orpha_substance_code": "ORPHA:93",
      "details": [
        "Recombinant human aspartylglucosaminidase(Medicinal product                        - 15/01/2015)Disease(s) concernedORPHA:93 Aspartylglucosaminuria",
        "Recombinant human aspartylglucosaminidase(Medicinal product                        - 15/01/2015)",
        "(Medicinal product                        - 15/01/2015)",
        "Disease(s) concernedORPHA:93 Aspartylglucosaminuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/418152?name=93&mode=orpha&region=&status=all",
          "text": "Recombinant human aspartylglucosaminidase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/93",
          "text": "ORPHA:93 Aspartylglucosaminuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/437286?name=93&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Adeno-associated viral vector serotype 9 encoding a codon-optimised human aspartylglucosaminidase transgene",
      "substance_url": "/en/drug/substance/604867?name=93&mode=orpha&region=&status=all",
      "substance_id": "604867",
      "regulatory_url": "/en/drug/regulatory/691630?name=93&mode=orpha&region=",
      "regulatory_id": "691630",
      "orpha_substance_code": "ORPHA:93",
      "details": [
        "Adeno-associated viral vector serotype 9 encoding a codon-optimised human aspartylglucosaminidase transgene(Medicinal product                        - 26/11/2024)Disease(s) concernedORPHA:93 Aspartylglucosaminuria",
        "Adeno-associated viral vector serotype 9 encoding a codon-optimised human aspartylglucosaminidase transgene(Medicinal product                        - 26/11/2024)",
        "(Medicinal product                        - 26/11/2024)",
        "Disease(s) concernedORPHA:93 Aspartylglucosaminuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/604867?name=93&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector serotype 9 encoding a codon-optimised human aspartylglucosaminidase transgene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/93",
          "text": "ORPHA:93 Aspartylglucosaminuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/691630?name=93&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:00:09.228556",
  "run_number": 1,
  "total_drugs_found": 3,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Aspartylglucosaminuria&orphaCode=93&name=93&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Aspartylglucosaminuria",
    "orphaCode": "93",
    "name": "93",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}